López-Ferrer, A, González-Cantero, A, Gutiérrez-Casbas, A, Martorell, A, Olveira, A, Madrid-Alvarez, MB, Nicolau, J, Carrascosa, JM, Baniandrés, O, Rivera, R, Ruiz-Villaverde, R, Queiro, R, de la Cueva, P. Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral. Dermatology and Therapy. 2026; 16(6)DOI:10.1007/s13555-026-01759-1. PMID:41999535. IF:4.200(Q1/1D).

Garbayo-Salmons, P, Molina-Leyva, A, Aguayo-Ortiz, RS, Vilarrasa, E. Chronic Venous Disease in Patients With Hidradenitis Suppurativa and Lymphedema: An Overlooked Problem. Jeadv Clinical Practice. 2026; 5(2)DOI:10.1002/jvc2.70300. PMID:. IF:(Q/D).

De Santis, M, Shore, ND, Nishiyama, H, Krawczynski, M, Seyitkuliev, A, Guerrero-Ramos, F, Zukov, R, Kawahara, T, Goeman, L, Powles, T, Gust, KM, Feyerabend, S, Patel, M, Kulkarni, GS, Lebret, T, Westgeest, HM, Quartilho, A, Dabrowska, A, Marsh, A, Palou, J. Durvalumab (D) in combination with BCG induction and maintenance (I plus M) therapy for BCG-naive, high-risk non-muscle-invasive bladder cancer (NMIBC): 5-year overall survival (OS) analysis and patient-reported outcomes (PROs) from POTOMAC.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(16_SUPPL)DOI:10.1200/JCO.2026.44.16_suppl.4624. PMID:. IF:41.900(Q1/1D).

Zaurito, P, Scilipoti, P, Longoni, M, de Angelis, M, Slusarczyk, A, Viti, A, Santangelo, A, Tremolada, G, Soria, F, Pradere, B, Krajewski, W, D'Andrea, D, Mari, A, Del Giudice, F, Pichler, R, Subiela, JD, Marcq, G, Gallioli, A, Afferi, L, Mastroianni, R, Simone, G, Albisinni, S, Mertens, LS, Laukhtina, E, Oberneder, K, Elena, JLR, Arandar, J, Puentedura, AL, Velascos, JC, Contieri, R, Hurle, R, Mori, K, Radziszewski, P, Shariat, SF, Gontero, P, Rouprêt, M, Montorsi, F, Salonia, A, Briganti, A, Moschini, M. Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(6)DOI:10.1016/j.urolonc.2026.111089. PMID:41934021. IF:2.300(Q2/5D).